[1]
Tanveer, M. and Ahsan Kamal 2026. FDAs new approval: yeztugo (lenacapavir): a longer lasting avenue against HIV. Journal of the Pakistan Medical Association. 76, 8 (Jul. 2026), 1401–1401. DOI:https://doi.org/10.47391/JPMA.33073.